AGARWALEYE500.20

Dr. Agarwal's Health Care Ltd.

· Pharma & Health
₹ CrorePeersAKUMSADVENZYMESALIVUSAARTIPHARMAARTIDRUGSAPLLTDCORONAHCGMcap ₹15,846 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment707.7926.5926.5
+ Capital Work-in-Progress143.9234.4234.4
+ Goodwill734.8735.8735.8
+ Other Intangibles448.0408.0408.0
+ Intangibles under Development9.39.29.2
+ Other Non-current Financial Assets97.3165.7165.7
Non-current Financial Assets97.3165.7165.7
+ Deferred Tax Assets32.026.926.9
+ Other Non-current Assets704.6862.5862.5
Total Non-current Assets2,877.53,368.83,368.8
Current Assets
+ Inventories80.394.094.0
+ Current Investments263.7152.3152.3
+ Trade Receivables123.6160.9160.9
+ Cash & Cash Equivalents103.690.690.6
+ Other Bank Balances154.538.738.7
+ Other Current Financial Assets49.913.413.4
Current Financial Assets695.3455.9455.9
+ Other Current Assets18.523.123.1
Total Current Assets794.1573.0573.0
Total Assets3,671.63,941.83,941.8
Equity
+ Equity Share Capital31.631.731.7
+ Other Equity / Reserves1,835.01,993.81,993.8
Equity — Owners of Parent1,866.62,025.52,025.5
+ Minority Interest60.294.294.2
Total Equity1,926.82,119.72,119.7
Liabilities
+ Borrowings — Non-current157.3133.3133.3
+ Other Non-current Financial Liab1,084.51,202.81,202.8
Non-current Financial Liabilities1,241.81,336.11,336.1
+ Provisions — Non-current18.323.923.9
+ Deferred Tax Liabilities7.00.60.6
Non-current Liabilities1,267.01,360.61,360.6
+ Borrowings — Current89.624.024.0
+ Trade Payables153.1149.3149.3
+ Other Current Financial Liab189.2227.7227.7
Current Financial Liabilities431.9400.9400.9
+ Provisions — Current3.49.09.0
+ Current Tax Liabilities14.922.822.8
+ Other Current Liabilities27.628.828.8
Current Liabilities477.8461.5461.5
Total Liabilities1,744.81,822.11,822.1
Total Equity & Liabilities3,671.63,941.83,941.8
Trade Payables — MSME split
+ Dues to Micro & Small — Current21.327.527.5
+ Dues to Other Creditors — Current131.8121.8121.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.